Novo Nordisk A/S
Ozempic drives up health-care costs, whether you can get it or not
About 165 million Americans rely on employer-sponsored health insurance, and yet workers may still not get the coverage they want — ...
Why Eli Lilly and Palo Alto Networks are both up on news from their competitors
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time ...
FTC sues drug middlemen for allegedly inflating insulin prices
Lina Khan, Chair of the Federal Trade Commission (FTC), testifies before the House Appropriations Subcommittee at the Rayburn House Office ...
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
The CEO of Novartis said Wednesday that the Swiss pharmaceutical giant does not plan to enter into the “frenzy” of ...
Eli Lilly releases new, cheaper form of weight loss drug
Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for roughly half its usual monthly ...
Eli Lilly weight loss drug cuts risk of developing diabetes in trial
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March ...